ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies
ASO Author Reflections
- 34 Downloads
The authors have no conflicts of interest to disclose.
- 2.Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–1787.CrossRefGoogle Scholar
- 4.Tsilimigras DI, Mehta R, Moris D, et al. A machine-based approach to preoperatively identify patients with the most and least benefit associated with resection for intrahepatic cholangiocarcinoma: an international multi-institutional analysis of 1,146 patients. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-08067-3.CrossRefPubMedGoogle Scholar
© Society of Surgical Oncology 2019